Home › Funds › Palo Alto Investors LP › CAPR
Palo Alto Investors LP position in CAPR
CAPRICOR THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 548,071 shares of CAPR (CAPRICOR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 0.77% of its reported portfolio and ranking #27 among its reported holdings. Palo Alto Investors LP has disclosed CAPR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's CAPR position evolved
Palo Alto Investors LP first disclosed a stake in CAPR in Q4 2025 at 226,304 shares (US$6.5M). The position peaked in Q1 2026 at 229,763 shares, worth US$7.0M. Across 4 filings, Palo Alto Investors LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 548,071 shares valued at US$5.2M — an increase of 318,308 shares quarter over quarter.. Notable position changes include a 139% increase in Q3 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 226.30K | $6.53M | New |
| Q1 2026 | 229.76K | $6.98M | Add |
| Q2 2026 | 229.76K | $5.53M | Hold |
| Q3 2026 | 548.07K | $5.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAPR and 13F data
CAPR (CAPRICOR THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in CAPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$28.5M), EcoR1 Capital, LLC (US$13.0M), Jones Hill Capital LP (US$8.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAPR
- RA CAPITAL MANAGEMENT, L.P. 3.01M sh · $28.54M · Q3 2026
- EcoR1 Capital, LLC 1.38M sh · $13.04M · Q3 2026
- Jones Hill Capital LP 892.53K sh · $8.45M · Q3 2026
- Boxer Capital Management, LLC 642.84K sh · $6.09M · Q3 2026
- DIADEMA PARTNERS LP 484.40K sh · $4.59M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held CAPR?
Palo Alto Investors LP has disclosed CAPR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Palo Alto Investors LP's current position in CAPR?
As of Q3 2026, Palo Alto Investors LP holds 548.07K shares of CAPR (CAPRICOR THERAPEUTICS INC), valued at $5.19M, representing 0.77% of its reported portfolio and ranking #27.
Has Palo Alto Investors LP been buying or selling CAPR?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in CAPR. The position peaked in Q1 2026 at 229.76K shares.
Which other funds hold CAPR?
Other major institutional holders of CAPR include RA CAPITAL MANAGEMENT, L.P., EcoR1 Capital, LLC, Jones Hill Capital LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.